<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Antidepressants, including selective serotonin reuptake inhibitors (SSRIs), are the third most prescribed drug class in the United States. It is estimated that 10% of Americans use antidepressants, representing a greater than 400% increase in use since 1994. Additionally, long-term use is becoming more common; 60% of SSRI users have been on treatment for over 2 years, and 14% of users have been on treatment for more than 10 years.
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup> With this dramatic increase in antidepressant use, comorbidities are now being discovered, including increased risk of fracture and decreased bone mineral densities in adolescents and young adults. Furthermore, in at-risk populations (e.g., post-menopausal women), SSRI use is associated with increased fracture risk, superseeding 
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>–
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup> other contraindicated drugs, including glucocorticoids
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup> and proton pump inhibitors.
 <sup>
  <xref ref-type="bibr" rid="CR7">7</xref>
 </sup>
</p>
